(18 Mar 2025, 12:53)

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million

Sun Pharmaceutical Industries rose 1.14% to Rs 1,725.55 after its subsidiary, TARO Pharmaceuticals Inc., completed the 100% acquisition of Antibe Therapeutics Inc. of Canada for a total consideration of $4.5 million.

Sun Pharmaceuticals Industries is a leading global pharmaceutical company with a specialty and generic presence and India's top pharma company.

The pharma major’s consolidated net profit increased 15.04% to Rs 2,903.38 crore on a 10.46% rise in revenue from operations to Rs 13,675.46 crore in Q3 FY25 over Q3 FY24

More News

(03-Apr-2025 16:39)
Dabur India drops on expecting net profit margin to decline 150-175 bps in Q4
(03-Apr-2025 15:34)
Advait Energy surges on emerging as L1 Bidder for MVCC project
(03-Apr-2025 15:27)
Marico expects revenue to grow in double digits in FY26
(03-Apr-2025 15:13)
Shakti Pumps gains on bagging Rs 12-cr order from MEDA

More Company News View Company Information

Hot Pursuit (18-Mar-2025 12:53)
Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million
Corporate News (18-Mar-2025 15:01)
Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada
Hot Pursuit (17-Mar-2025 13:00)
Sun Pharmaceuticals Industries Ltd soars 0.96%, gains for fifth straight session
Hot Pursuit (12-Mar-2025 13:05)
Sun Pharmaceuticals Industries Ltd rises for third straight session
Corporate News (10-Mar-2025 09:02)
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics
Hot Pursuit (10-Mar-2025 10:15)
Sun Pharma to acquire 100% stake in Nasdaq-listed Checkpoint Therapeutics
Hot Pursuit (24-Feb-2025 13:35)
Sun Pharmaceuticals Industries Ltd eases for fifth straight session

Hot Pursuit News

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million